To connect, or not to connect? Team article featured in PMPS
Paul Greenhalgh, Charlotte Harris and Tom Etheridge recently co-wrote an article for Pharmaceutical Manufacturing and Packing Sourcer (PMPS), where they explore and highlight the benefits of using connected devices.
A connected device could be helpful in monitoring adherence, learning about patient behaviour, or helping patients engage with their therapy – all of which are linked to attaining better clinical outcomes. In contrast to this, several barriers are met when ‘going connected’, including high costs, lengthy development time, and the unwillingness of some patients to share their data. With all of these factors to consider, how can it be decided whether a connected device is right or not, and where is the real value in developing one?
The opportunities a connected system offers may reach way beyond the practical issues of sensing and confirming correct use. This article presents some ways of breaking down the question into more manageable chunks, which should help to assess the full breadth of opportunities.
You can read the article on the PMPS website here.